Newly introduced controlled substance e-prescribing bill gets industry support
ARLINGTON, Va. — Two members of Congress have introduced legislation that would mandate electronic prescribing for controlled substances under Medicare Part D. Reps. Katherine Clark, D-Mass., and Markwayne Mullin, R-Okla., introduced the Every Prescription Conveyed Securely Act in the House Wednesday afternoon.
“Opioids claim nearly a hundred lives a day, and parents across the country worry they will be next to get the call their child has overdosed,” Clark said. “Modernizing public health practices to include electronic prescriptions will curb the over-prescribing of opioids, eliminate the costs and inefficiencies of paperwork, and strengthen communication between doctors and patients. Congress should come together to pass this commonsense solution to prevent overdoses and save lives.”
“We believe the legislation is an important step in combatting the abuse and diversion of prescription opioid medications. Electronic prescribing of controlled substances adds new dimensions of safety and security,” he wrote. “Prescribers can more easily track the controlled substance prescriptions a patient has received. Additionally, electronic controlled substance prescriptions cannot be altered, cannot be copied, and are electronically trackable. Furthermore, the federal DEA rules for electronic controlled substances prescriptions establish strict security measures, such as two-factor authentication, that reduce the likelihood of fraudulent prescriptions.”
In the letter, Anderson described its consistent support for the advancement of electronic prescribing, as well the evolution of public policy to leverage advantages of the technology. He also expressed appreciation for the legislators’ efforts to craft the legislation in a way that acknowledges and addresses instances in which electronic prescribing is not feasible or may not be possible.
“Oklahoma is consistently ranked among the highest in the nation in overdose deaths from prescription painkillers,” Mullin said. “Despite federal and local efforts, we have seen the opioid epidemic creep into our communities at alarming rates. We need to ensure that patients are receiving opioids only when absolutely necessary and take precautionary measures to prohibit them from falling into the wrong hands. Our bill, the EPCS Act, aims to close a dangerous loophole that has been fueling the problem of excessively prescribed opioids.”
The introduction of H.R. 3528 follows another recent and positive development for the use of e-prescribing for controlled substances. NACDS in July applauded a DEA guidance regarding the forwarding of such prescriptions. By explicitly stating that a DEA-registered pharmacy may forward to another DEA-registered pharmacy an unfilled, original e-prescription for controlled substances that the pharmacy is unable to fill for any reason, the guidance “encourages the use of electronic prescribing for controlled substances, and removes a substantial barrier to doing so,” Anderson said.
APhA Foundation names 2017 Pinnacle Award honorees
American Pharmacies reports results from using FDS’ RxCompass
FORT WORTH, Texas — Buying cooperative American Pharmacies has released the results of two studies showing the impact of implementing FDS’ RxCompass data reporting tool powered by myDataMart. The results, shared at its Annual Meeting in San Antonio, shows that RxCompass reports generated gains of more than 1,800 prescription refills and net revenues of $171,000 at six APRx member pharmacies in a 33-week period, and five others saw increased revenues of 108,000 in six weeks.
“The daily and weekly performance reports generated by RxCOMPASS drive value by identifying key operational opportunities like gross profits, prescription revenues and missed refills,” APRx VP sourcing and consulting services John Cooper said. “In particular, the Refill-on-Time report that is pushed daily to subscribing pharmacies has proven highly effective at increasing refill volume and improving timeliness.”
APRx partnered with FDS in an effort to help its member independent pharmacies with a comprehensive business intelligence tool to offer a deeper look at their pharmacy operations. RxCompass identifies dispensing and operational trends, as well as clinical services opportunities, through analysis of dispensing data in the pharmacy management system.
“RxCompass, powered by myDataMart, offers APRx member pharmacies a robust array of dashboards and graphical reports to help them manage patient adherence, Star performance measures, new and lost patients, dispensing analysis and more,” FDS EVP business development Rich Bukovinsky said. “It is compatible with most pharmacy systems and supports population health management efforts, such as vaccination tracking, to ensure pharmacies can leverage every opportunity to improve patient outcomes, strengthen the pharmacy-patient relationship and maximize revenues.”
In the 16-week study of five pharmacies, using RxCompass helped drive gains of two fills per patient, increased revenue-per-script of more than $108 and increased per-patient profit by more than $29.
Besides offering the Refill-on-Time function, RxCompass also offers a Daily Performance Report that shows a snapshot of the pharmacy’s previous-day performance, as well as a monthly report displaying missing and new patients and the pharmacy’s Star Ratings Compliance Scorecard for each claim adjudication plan.
“One of my most compliant stores was losing money, so I looked at the performance report and discovered they were using a size on a generic that was not covered,” APRx board member and owner of one of the pharmacies studied, Alton Kanak, said. “It just took one phone call to say ‘hey, use a different size,’ and they suddenly became profitable.”